Dateline: Mon, 21 Mar 2005
freeNewsArticles Story Summary: “CEDAR GROVE, NJ /Send2Press Newswire/ — New Jersey based Optimal Therapeutics announces the signings of licensing agreements for trademarked ingredients in their Phosoplex Joint Formulation. BioCell Collagen II from BioCell Technology LLC and Nextrutine(R) from Next Pharmaceutical are exciting ingredient additions to an already potent joint health formula.”
A R T I C L E:
CEDAR GROVE, NJ /Send2Press Newswire/ — New Jersey based Optimal Therapeutics announces the signings of licensing agreements for trademarked ingredients in their Phosoplex Joint Formulation. BioCell Collagen II from BioCell Technology LLC and Nextrutine(R) from Next Pharmaceutical are exciting ingredient additions to an already potent joint health formula.
Company spokesperson Camille Westhoff states: “Phosoplex with the addition of these two key ingredients puts Optima Therapeutics at the forefront of joint health and pain relief. It’s great to be associated with a product like Phosoplex because it can really change a person’s quality of life.”
Optimal Therapeutics also produces Fematril, Viastat, Zalestra, Zyroxin, Neurovar, Immunitril and other revolutionary lifestyle products.
Optimal Therapeutics products can be purchased online at www.BodEStore.com or by way of Amazon.
###
Copyright © 2005 by Optimal Therapeutics and Send2Press® Newswire, a service of Neotrope® – all rights reserved. Information believed accurate but not guaranteed. Sourced on: freeNewsArticles.com.
• Story Title: New Jersey Based Optimal Therapeutics Announces the Signing of Licensing Agreement for the Trademarked Ingredient Nextrutine(R) in Their Phosoplex Joint Formulation
• REFERENCE KEYWORDS/TERMS: , , , , Health, Diet and Fitness, , , .
IMPORTANT NOTICE: some content which is considered “old” or “archival” may reference an event which has already occurred; some content possibly considered “advertorial” may also reference a promotion or time-limited/sensitive offering, and in all of these instances certain material may no longer be valid. For notably stale content, you should directly contact the company/person mentioned in the text (Optimal Therapeutics); this site cannot assist you with information about products/services mentioned in the news article, nor handle any complaints or other issues related to any person/company mentioned or promoted in the above text. Information believed accurate but not guaranteed as of original date of story [Mon, 21 Mar 2005 17:06:00 GMT].
USE THIS CONTENT FOR FREE: To use this content in your newspaper, broadcast outlet, news portal, blog/ezine or similar, free of cost, CLICK HERE to learn how.